시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
응고 검사 시장 규모, 점유율, 성장 분석 : 제품별, 검사별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Coagulation Testing Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Test (Complete Blood Count (CBC), Factor V Assay), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032
상품코드 : 1687540
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,657,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,957,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,258,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

응고 검사 시장 규모는 2023년에 38억 달러로 평가되며, 2024년 42억 6,000만 달러에서 2032년에는 107억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 12.2%로 성장할 전망입니다.

세계 응고 검사 시장은 심혈관 질환의 유병률 증가, 혈액 질환, 고령화 등 다양한 요인으로 인해 강력한 성장세를 보이고 있습니다. 혈우병 및 폰 빌레브란트병과 같은 질환의 유병률 증가는 응고 검사 서비스에 대한 수요를 크게 증가시키고 있습니다. 또한 수술 및 외상 증가로 인해 적시에 정확한 응고 진단이 필요하게 되었습니다. 그러나 엄격한 규제 요건은 시장 역학에 큰 영향을 미치고 있으며, 신규 진출기업에게 도전이 되고 있습니다. 품질 기준을 준수하고 규제 당국의 승인을 획득하는 것은 이 분야에서 발판을 마련하고자 하는 시장 진출기업에게 중요한 요소입니다. 전반적으로 응고 검사 시장은 이러한 변화하는 헬스케어 수요에 따라 지속적으로 성장할 수 있는 태세를 갖추고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

응고 검사 시장 규모 : 제품별 & CAGR(2025-2032)

응고 검사 시장 규모 : 검사별 & CAGR(2025-2032)

응고 검사 시장 규모 : 기술별 & CAGR(2025-2032)

응고 검사 시장 규모 : 용도별 & CAGR(2025-2032)

응고 검사 시장 규모 : 최종사용자별 & CAGR(2025-2032)

응고 검사 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Coagulation Testing Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.26 billion in 2024 to USD 10.71 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).

The global Coagulation Testing Market is experiencing robust growth, fueled by various factors including the rising incidence of cardiovascular diseases, blood disorders, and an aging population. The increased prevalence of conditions like hemophilia and von Willebrand disease has significantly heightened the demand for coagulation testing services. Moreover, the escalation in surgical procedures and trauma cases necessitates timely and accurate coagulation diagnostics. However, stringent regulatory requirements highly influence the market dynamics, posing entry challenges for new players. Compliance with quality standards and obtaining regulatory approvals are critical elements for market participants hoping to establish a foothold in this expanding sector. Overall, the coagulation testing market is poised for continued growth amid these evolving healthcare demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coagulation Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coagulation Testing Market Segments Analysis

Global Coagulation Testing Market is segmented by Product, Test, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Consumables, Reagents And Standards, Controls and Calibrations. Based on Test, the market is segmented into Complete Blood Count (CBC), Factor V Assay, Fibrinogen Level, Prothrombin Time, Platelet Count, Thrombin Time, Bleeding Time and Others. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Others. Based on Application, the market is segmented into Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Other. Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Point-of-Care Testing and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coagulation Testing Market

The rising incidence of cardiovascular diseases, along with a globally aging population, highlights the increasing demand for coagulation testing as a critical diagnostic instrument. Furthermore, technological advancements in diagnostic methods, such as optical and electrochemical coagulation testing techniques, significantly improve the precision and efficiency of results. This progress is fueling the widespread adoption of coagulation testing across various healthcare environments, making it an essential component for effective patient management. As healthcare providers seek reliable tools for diagnosing and monitoring coagulation disorders, the market for these testing methods continues to expand, reflecting the need for enhanced patient care and outcomes.

Restraints in the Coagulation Testing Market

A significant restraint in the coagulation testing market is the inherent complexities involved in standardizing testing procedures, particularly due to variations in results obtained in different laboratories and clinical environments. These discrepancies create challenges for healthcare professionals who must interpret the results accurately, potentially compromising the overall reliability of coagulation tests. Such inconsistencies not only impede effective diagnosis and treatment but also undermine confidence in testing protocols, ultimately affecting patient care. Addressing these variations is essential to enhance the consistency and accuracy of coagulation testing across diverse healthcare settings.

Market Trends of the Coagulation Testing Market

The coagulation testing market is experiencing a significant shift towards point-of-care (POC) testing, driven by the increasing demand for rapid and decentralized diagnostic solutions. This trend is primarily motivated by the need for swift decision-making in emergency situations and outpatient care settings. Technological advancements are enhancing the development of portable, user-friendly coagulation testing devices, making them easier to adopt across diverse healthcare environments. As healthcare providers seek to improve patient outcomes through timely interventions, the growing preference for POC testing is expected to shape the future landscape of the coagulation testing market, fostering innovation and expanding accessibility.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Coagulation Testing Market Size by Product & CAGR (2025-2032)

Global Coagulation Testing Market Size by Test & CAGR (2025-2032)

Global Coagulation Testing Market Size by Technology & CAGR (2025-2032)

Global Coagulation Testing Market Size by Application & CAGR (2025-2032)

Global Coagulation Testing Market Size by End-User & CAGR (2025-2032)

Global Coagulation Testing Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기